Geneoscopy is a molecular diagnostics company committed to providing safe, effective, and innovative non-invasive tests to improve the diagnosis, monitoring and treatment of gastrointestinal diseases. The company has developed a proprietary method to isolate eukaryotic biomarkers from stool samples. Our lead product is a screening tool to noninvasively identify patients with colorectal cancer and precancercous adenomas with high sensitivity. We are now actively working in IBD to help assess mucosal healing status, in a noninvasive fashion. Geneoscopy’s RNA extraction platform enables access to a variety of clinically relevant biomarkers such as GI enterocytes, lymphocytes, and can assess the host-microbiome interaction. This allows for opportunities as standalone tests, companion diagnostics, and/or clinical trials tools.

Developed Precision Medicine and Nurse Education strategy and led its execution across all US Oncology therapeutic areas. Set and executed the strategic direction for all diagnostic and nurse education efforts of the oncology business team.

Caris is a leading innovator in molecular science focused on oncology precision medicine. They perform cancer genomic (DNA), transcriptomic (RNA) and immunochemistry (protein) testing to guide more precise and individualized therapeutic decisions for treating physicians and the patients they serve.

Responsible for the global commercialization activities and on-market support for product lines. Led the development of marketing plan for product areas and served as lead message developer and communicator of product positioning and branding. Oversaw the development of global marketing tools, programs, and activities in support of the products.

Managed the identification and evaluation of new external strategic business relationships involving a wide range of partners including technology providers, strategic suppliers, channel partners and academic collaborators. Led cross-functional teams including representatives from marketing, R&D, finance, and legal departments to drive the development of partnering related business cases for presentation to executive management.

Responsible for the development of marketing strategies, tools, and tactics to drive growth, profitability, and predictability for the primary staining market segment. Provided leadership to accomplish strategic and tactical business objectives.

Responsible for the global commercialization and implementation of specific product portfolio. Provided both strategic and tactical expertise in developing worldwide market analyses and implementing the resulting outcome into the annual marketing plan.

Boutique Mergers & Acquisitions firm specializing in the wireless telecommunications industry. Directed the mergers and acquisitions activity of the firm through the development of strategic, regional portfolios of like-kind companies/assets in the wireless telecommunications industry.